Gao ZL - Search Results

1

[Three shock hypotheses that may induce liver failure].

Ye YN, Gao ZL. Ye YN, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2009 Aug;17(8):638-40. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19719932 Review. Chinese. No abstract available.

2

[The clinical features and natural history of post-transfusion hepatitis C].

Chong YT, Lin CS, Zhao ZX, Lin GL, Li JG, Gao ZL. Chong YT, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2006 Mar;14(3):199-201. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16556415 Chinese.

3

[Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients].

Deng H, Chong YT, Han XY, Zhang FC, Peng XM, Gao ZL, Yao JL. Deng H, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2006 Oct;14(10):721-4. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 17064461 Chinese.

4

[Optimization of cultivation methods of MSCs from hepatitis B patients and investigation of their biological characteristics].

Peng L, Li H, Gu L, Peng XM, Huang YS, Gao ZL. Peng L, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2007 Jul;15(7):517-20. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17669241 Chinese.

5

[A multicenter clinical study of nafate for treatment of hepatic fibrosis in patients with chronic liver diseases].

Li Q, Zhang YJ, Shi GF, Bian L, An P, Lin BL, Gao ZL. Li Q, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2007 Oct;15(10):749-52. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17963601 Clinical Trial. Chinese.

6

[Hepatitis B virus X protein suppressing adriamycin-induced apoptosis of HepG2 cells].

Fan HM, Yang L, Xie QF, Han XY, Wu M, Zhang FC, Yao CL, Li G, Gao ZL. Fan HM, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2008 Jan;16(1):25-8. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18226339 Chinese.

7

[The predictive value of ALT, HBeAg and HBV DNA levels at baseline and the degree of HBV suppression at week 12 adefovir dipivoxil treatment to the efficacy of it at week 52 in patients with HBeAg-positive chronic hepatitis B].

Xie DY, Lin BL, Xu QH, Chen YM, Lu WL, Li JG, Gao ZL. Xie DY, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2008 May;16(5):341-4. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18510844 Chinese.

8

[Application and value of anti-inflammation and liver protection therapy in the treatment of liver diseases].

Zhang LX, Gao ZL, Hu XY, Fan ZP, Qu JH, Luo SQ. Zhang LX, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2008 Sep;16(9):714-6. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18822221 Chinese. No abstract available.

9

[Intestinal microenvironment of patients with liver disease and its effect on immunity].

Zhang GZ, Gao ZL. Zhang GZ, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2008 Sep;16(9):719-20. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18822223 Review. Chinese. No abstract available.

10

[Association between the serum HBV DNA loads normalized to hepatic parenchyma cell volume and the liver histopathologic inflammation gradings in the immune clearance phase].

Li XJ, Xie SB, Zang XH, Zang Y, Zhao ZX, Ke WM, Gao ZL. Li XJ, et al. Among authors: gao zl. Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):740-4. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19874688 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters